<SEC-DOCUMENT>0001213900-20-041251.txt : 20201207
<SEC-HEADER>0001213900-20-041251.hdr.sgml : 20201207
<ACCEPTANCE-DATETIME>20201207111840
ACCESSION NUMBER:		0001213900-20-041251
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20201204
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201207
DATE AS OF CHANGE:		20201207

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OptimizeRx Corp
		CENTRAL INDEX KEY:			0001448431
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				261265381
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38543
		FILM NUMBER:		201371721

	BUSINESS ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
		BUSINESS PHONE:		248-651-6558

	MAIL ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea131150-8k_optimizerx.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(d) OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934<BR>
Date of Report (Date of earliest event reported): December 4, 2020<BR>
<BR>
<BR>
<FONT STYLE="font-size: 12pt"><U>OptimizeRx Corporation</U></FONT><BR>
(Exact name of registrant as specified in its charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 33%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Nevada</FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">001-38543</FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 33%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">26-1265381</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction of incorporation)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Commission File Number)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(I.R.S. Employer Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 66%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">400 Water Street, Suite 200, Rochester, MI</FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 33%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">48307</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Address of principal executive offices)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Zip Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Registrant&rsquo;s telephone number, including
area code: <U>248.651.6568</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 50%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Former name or former address, if changed since
last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Emerging growth company&nbsp;&nbsp;&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Securities registered pursuant to Section 12(b) of the Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 36%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Title of each class</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 28%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Trading symbol</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 34%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Name of each exchange on which registered</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Common Stock</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">OPRX</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Nasdaq Capital Market</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>SECTION 8 &ndash; Other Events</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 8.01</B></TD><TD><B>Other Events</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On December 4, 2020, we issued a press release announcing a partnership
with Komodo Health, a data-driven healthcare software company with access to the broadest array of real-world data across patients,
practitioners, and health systems. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The information in Item 8.01 of this Current
Report on Form 8-K (including Exhibit 99.1) shall not be deemed &ldquo;filed&rdquo; for purposes of Section 18 of the Securities
Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;) or otherwise subject to the liabilities of that section, nor shall it be
deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth
by specific reference in such a filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>SECTION 9 &ndash; Financial Statements and Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 9.01</B></TD><TD><B>Financial Statements and Exhibits</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; background-color: rgb(204,238,255)">
<TD STYLE="width: 1in; text-align: left">99.1</TD><TD STYLE="width: 0%"></TD><TD STYLE="text-align: justify"><A HREF="ea131150ex99-1_optimizerx.htm" STYLE="-sec-extract: exhibit">Press release, dated December 4, 2020</A></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>OptimizeRx Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 33%">/s/ Douglas Baker</TD>
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="width: 33%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>Douglas Baker</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>Chief Financial Officer</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>Date: December 7, 2020</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea131150ex99-1_optimizerx.htm
<DESCRIPTION>PRESS RELEASE, DATED DECEMBER 4, 2020
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 87px; width: 371px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>OptimizeRx Partners with Komodo Health
to Expand Life Sciences Support at Point-of-Care</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>Komodo&rsquo;s Extensive Healthcare Map Powers
Precise Care Milestone Mapping, <BR>
Improving Support for Providers and Patients</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ROCHESTER,
Mich. &ndash; December 7, 2020</B> &ndash; OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for
life science companies, physicians and patients, has partnered with Komodo Health, <FONT STYLE="background-color: white">a data-driven
healthcare software company with access to</FONT> the broadest array of real-world data across patients, practitioners, and health
systems<FONT STYLE="background-color: white">. </FONT></FONT><BR>
<BR>
<FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">The partnership integrates Komodo&rsquo;s comprehensive
Healthcare Map</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">with <FONT STYLE="background-color: white">OptimizeRx&rsquo;s
digital health and communication platform to power </FONT>OptimizeRx&rsquo;s <FONT STYLE="background-color: white">novel real-world
evidence (RWE) solution</FONT>. The solution leverages automated intelligence through machine-learning and APIs to seamlessly deliver
point-of-care messaging.</FONT><BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Komodo&rsquo;s
real-world visibility into millions of patient journeys and healthcare provider actions across all therapeutic areas will enable
OptimizeRx to deliver richer insights to physicians through its digital health network. This visibility expands OptimizeRx&rsquo;s
total addressable audience, giving its life science clients unparalleled ability to reach and support clinicians at precise moments
at the point-of-care. The API-driven integration supplements OptimizeRx&rsquo;s recent platform enhancement involving the application
of advanced analytics using machine learning methods applied to real-world-data (RWD). </FONT><BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&ldquo;Accurate, timely, real-world patient insights through digital
platforms have become critically important given that COVID-19 has fundamentally changed how providers deliver care,&rdquo; said
Jason Prestinario, head of healthcare solutions at Komodo Health. &ldquo;Pairing our comprehensive patient insights with OptimizeRx&rsquo;s
powerful provider communications platform will enable a transformative patient experience at the point-of-care.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As the COVID-19 pandemic has demonstrated, prescribed therapies
can change or evolve rapidly. Yet there are few channels currently available that can efficiently reach healthcare providers with
timely insights on new therapies and other important care considerations. Scientific advances can also emerge rapidly, but it often
takes 10-15 years for an important medical breakthrough to become the standard of care. These gaps can lead to sub-optimal care
and outcomes for patients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&ldquo;As our digital health footprint expands with more manufacturers
coming onto our platform, we continue working relentlessly to steward health data in ways that can efficiently yield better outcomes
as well as provide savings for patients,&rdquo; said Steve Silvestro, chief commercial officer at OptimizeRx. &ldquo;Our partnership
with Komodo Health enables us to augment the physician workflow with actionable insights. By providing additional real-time critical
information for clinicians dealing with complex healthcare scenarios, we can improve the patient and physician experience and ultimately
treatment outcomes.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>About Komodo Health</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Komodo Health believes that smarter, more innovative use of data
and analytics is essential for reducing disease burden. We apply advanced data science techniques to our first-of-its-kind Healthcare
Map&trade;, which tracks the unique patient journeys of over 320 million patients. Using our cloud-based platform and application
suite, we empower a multitude of healthcare stakeholders &mdash; life science companies, healthcare payers and providers, patient
advocacy groups, and others &mdash; to create a more cost-effective, value-driven healthcare system. For more information, visit
komodohealth.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>About OptimizeRx</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">OptimizeRx is a digital health company that provides communications
solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions
of patients through a proprietary network, the OptimizeRx digital health platform helps patients afford and stay on medications.
The platform unlocks new patient and physician touchpoints for life science companies along the patient journey, from point-of-care,
to retail pharmacy, through mobile patient engagement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">For more information, follow the company on&nbsp;Twitter,&nbsp;LinkedIn&nbsp;or
visit&nbsp;www.optimizerx.com.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Important Cautions Regarding Forward Looking Statements</B><BR>
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended,
and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make
an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements,
which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking
statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject
to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially
from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>OptimizeRx&nbsp;Contact</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Doug Baker, CFO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Tel (248) 651-6568 (x807)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">dbaker@optimizerx.com&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Media Relations Contact</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Maira Alejandra, Media Relations Manager</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Tel (754) 245-7070&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">malejandra@optimizerx.com<FONT STYLE="color: #0563C1"><U>&nbsp;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Investor Relations Contact</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Ron Both, CMA&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Tel (949) 432-7557&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Email Contact</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>
<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !7 7,# 2(  A$! Q$!_\0
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M _AU^@KU?7>= U'_ *]I/_037#_!A1_8-^>YN!S_ ,!%"?N@=\NGVB1")+6
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
8B@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
